Showing results 334 to 353 of 391
< previous
next >
| Issue Date | Title | Author(s) |
| 2020-06-18 | SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. | Singh, Y; Gupta, G; Kazmi, I; Al-Abbasi, FA; Negi, P; Chellappan, DK; Dua, K |
| - | Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies | Rathore, C; Hemrajani, C; Sharma, AK; Gupta, PK; Jha, NK; Aljabali, AAA; Gupta, G; Singh, SK; Yang, J-C; Dwivedi, RP; Dua, K; Chellappan, DK; Negi, P; Tambuwala, MM |
| 2022-10 | Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases | Ashique, S; De Rubis, G; Sirohi, E; Mishra, N; Rihan, M; Garg, A; Reyes, R-J; Manandhar, B; Bhatt, S; Jha, NK; Singh, TG; Gupta, G; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K |
| 2020-01-01 | Small interfering RNA for cancer treatment: overcoming hurdles in delivery | Charbe, NB; Amnerkar, ND; Ramesh, B; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Khadse, SC; Satheeshkumar, R; Satija, S; Metha, M; Chellappan, DK; Shrivastava, G; Gupta, G; Negi, P; Dua, K; Zacconi, FC |
| 2022-06-01 | Sodium alginate based drug delivery in management of breast cancer | Shaikh, MAJ; Alharbi, KS; Almalki, WH; Imam, SS; Albratty, M; Meraya, AM; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Altamimi, ASA; Singh, Y; Singh, SK; Dua, K; Gupta, G |
| 2023-03-09 | Sodium alginate-based drug delivery for diabetes management: A review. | Shaikh, MAJ; Gupta, G; Goyal, A; Gupta, MM; Afzal, O; Altamimi, ASA; Alzarea, SI; Almalki, WH; Kazmi, I; Negi, P; Singh, SK; Dua, K |
| - | Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms | Prasher, P; Sharma, M; Singh, SK; Gulati, M; Chellappan, DK; Rajput, R; Gupta, G; Ydyrys, A; Kulbayeva, M; Abdull Razis, AF; Modu, B; Sharifi-Rad, J; Dua, K |
| 2022-01-10 | Studies on Synthesis and Characterization of Fe3O4@SiO2@Ru Hybrid Magnetic Composites for Reusable Photocatalytic Application | Kumar, AP; Bilehal, D; Desalegn, T; Kumar, S; Ahmed, F; Murthy, HCA; Kumar, D; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Lee, Y-I |
| 2020-10-15 | Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld. | Chan, Y; Ng, SW; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| 2022-02-25 | Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals. | Alharbi, KS; Singh, Y; Prasad Agrawal, G; Altowayan, WM; Almalki, WH; Sharma, A; Singh, SK; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2021-01-01 | Synthesis and anticancer properties of ‘Azole’ based chemotherapeutics as emerging chemical moieties: A comprehensive review | Prasher, P; Sharma, M; Zacconi, F; Gupta, G; Aljabali, AAA; Mishra, V; Tambuwala, MM; Kapoor, DN; Negi, P; Pinto, TDJA; Singh, I; Chellappan, DK; Dua, K |
| 2019-01-01 | Targeting bacterial biofilms in pulmonary diseases in pediatric population | Dua, K; Gupta, G; Chellappan, DK; Shukla, S; Hansbro, PM |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2022-10-14 | Targeting inflammation: a potential approach for the treatment of depression. | Bhatt, S; Devadoss, T; Jha, NK; Baidya, M; Gupta, G; Chellappan, DK; Singh, SK; Dua, K |
| - | Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach | Bhatt, S; Anitha, K; Chellappan, DK; Mukherjee, D; Shilpi, S; Suttee, A; Gupta, G; Singh, TG; Dua, K |
| 2022-03-22 | Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases. | Shukla, SD; Shastri, MD; Vanka, SK; Jha, NK; Dureja, H; Gupta, G; Chelappan, DK; Oliver, BG; Dua, K; Walters, EH |
| 2020-10-05 | Targeting interleukins in chronic airway diseases using advanced drug delivery. | Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| - | Targeting LIN28: a new hope in prostate cancer theranostics | Shrivastava, G; Aljabali, AAA; Shahcheraghi, SH; Lotfi, M; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Dureja, H; Pabari, RM; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Negi, P; Goyal, R; Dua, K; Gupta, G; Serrano-Aroca, Á; Bahar, B; Barh, D; Panda, PK; Takayama, K; Lundstorm, K; McCarron, P; Bakshi, H; Tambuwala, MM |
| 2018-12 | Targeting microRNAs using nanotechnology in pulmonary diseases. | Dua, K; Chellappan, DK; Singhvi, G; de Jesus Andreoli Pinto, T; Gupta, G; Hansbro, PM |
| 2022-08 | Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems | Prasher, P; Sharma, M; Singh, SK; Gulati, M; Jha, NK; Gupta, PK; Gupta, G; Chellappan, DK; Zacconi, F; de Jesus Andreoli Pinto, T; Chan, Y; Liu, G; Paudel, K; Hansbro, PM; George Oliver, BG; Dua, K |
